there could potentially be further future applications for compounds targeting them. You can read all this and more here:
• www.science.org/doi/10.1126/...
• asrc.gc.cuny.edu/headlines/20...
• www.nih.gov/news-events/...
• www.sciencenews.org/article/anti...
• www.gavi.org/vaccineswork...

The next phase of the research will focus on advancing the most promising compounds into clinical trials. The researchers anticipate Phase I trials beginning in 2028 after completing preclinical development. Since glycans have also been implicated in cancer and immune disorders,

I doubt that'll happen, but this paypro nonsense is making me not wanting to open for commissions for unforseenable future.

🇪🇺Misleading headlines: #chatcontrol is not dead, it is being privatized! 🚨

EU governments voted today for:
🔍 Warrantless mass surveillance
🆔 Mandatory ID for everyone (End of anonymity)
🚫 Digital house arrest for teens

The fight continues! 👇 […]

[Original post on digitalcourage.social]